A COMPARISON OF POLLEN GRAINS OF POTENTILLA RECTA L. (ROSACEAE) GROUPS A, B & C IN TURKEY

WOS: 000279569300009

AMINO ACID AND VITAMIN CONTENT OF PROPOLIS COLLECTED BY NATIVE CAUCASICAN HONEYBEES

The polyphenol content of propolis has received a lot of attention due to the benign biological properties noted in the chemical composition studies. However, there are very limited studies about other chemical components found in trace amounts in nature which contribute to the therapeutic properties of propolis. The present study, therefore, investigated the amino acid and vitamin composition of propolis. Propolis harvested by 60 colonies of Apis mellifera caucasica belonged to local non-migratory beekeepers. The A. m. caucasica is known for its distinctive propolis collecting capability which native to the secluded Ardahan Province of Turkey. Vitamin (Thiamine, Riboflavin) combinations of propolis were determined using the HPLC (High-Performance Liquid Chromatography) fluorescent detector. An amino acid analysis was also performed with the UFLC (Ultra-Fast Liquid Chromatography) system consisting of binary pump and UV/VIS. Our findings record that the vitamin and amino acid content of propolis samples collected from three areas of different altitudes in the same region differed from each other. Vitamin 61 content and Vitamin B2 content ranged between 0.025-0.16 mg/100g, and 0.304-0.777mg/100g, respectively. A maximum amount of amino acid was reported as leucine, while a minimum amount of amino acid was seen as tryptophan in Ardahan propolis. Consequently, the vitamin and amino acid content of propolis, which derived from secondary plant metabolites of resin, varied depending on their geographical altitudes. Those vitamin and amino acids found in the propolis composition are believed to have beneficial therapeutic properties

Amino Acid and Vitamin Content of Propolis Collected by Native Caucasican Honeybees

The polyphenol content of propolis has received a lot of attention due to the benign biological properties noted in the chemical composition studies. However, there are very limited studies about other chemical components found in trace amounts in nature which contribute to the therapeutic properties of propolis. The present study, therefore, investigated the amino acid and vitamin composition of propolis. Propolis harvested by 60 colonies of Apis mellifera caucasica belonged to local non-migratory beekeepers. The A. m. caucasica is known for its distinctive propolis collecting capability which native to the secluded Ardahan Province of Turkey. Vitamin (Thiamine, Riboflavin) combinations of propolis were determined using the HPLC (High-Performance Liquid Chromatography) fluorescent detector. An amino acid analysis was also performed with the UFLC (Ultra-Fast Liquid Chromatography) system consisting of binary pump and UV/VIS. Our findings record that the vitamin and amino acid content of propolis samples collected from three areas of different altitudes in the same region differed from each other. Vitamin B1 content and Vitamin B2 content ranged between 0.025-0.16 mg/100g, and 0.304-0.777mg/100g, respectively. A maximum amount of amino acid was reported as leucine, while a minimum amount of amino acid was seen as tryptophan in Ardahan propolis. Consequently, the vitamin and amino acid content of propolis, which derived from secondary plant metabolites of resin, varied depending on their geographical altitudes. Those vitamin and amino acids found in the propolis composition are believed to have beneficial therapeutic properties

Investigation of Carbapenemases in Carbapenem-Resistant Escherichia coli and Klebsiella pneumoniae Strains Isolated in 2014 in Turkey

Carbapenems are the choice of treatment in infections caused by multidrug resistant Enterobacteriaceae. In recent years carbapenem-resistant Enterobacteriaceae isolates due to carbapenemases have been increasingly reported worldwide. Multicenter studies on carbapenemases are scarce in Turkey. The aim of this study was to determine the distribution of carbapenemases from different parts of Turkey as a part of the European Survey of Carbapenemase Producing Enterobacteriaceae (EuSCAPE) project. Beginning in November 2013, carbapenem-resistant isolates resistant to at least one of the agents, namely imipenem, meropenem, and ertapenem were sent to the coordinating center. Minimum inhibitory concentrations for these carbapenems were determined by microdilution tests following EUCAST guidelines. Production of carbapenemase was confirmed by combination disk synergy tests. Types of carbapenemases were investigated using specific primers for VIM, IMP; NDM, KPC and OXA-48 genes by multiplex polymerase chain reaction. In a six month period, 155 suspected carbapenemase-positive isolates were sent to the coordinating center of which 21 (13.5%) were E.coli and 134 (86.5%) were K.pneumoniae. Nineteen (90.5%) strains among E.coli and 124 (92.5%) strains among K.pneumoniae were shown to harbour at least one carbapenemase gene by molecular tests, with a total of 92.3% (143/155). Carbapenemases were determined as a single enzyme in 136 strains (OXA-48: 84.6%; NDM: 6.3%; VIM: 2.8%; IMP: 1.4%) and as a combination in seven isolates (OXA-48 + NDM: 2.1%; OXA-48 + VIM: 2.1%; VIM + NDM: 0.7%). KPC was not detected in any of the isolates. According to the microdilution test results, resistance to imipenem, meropenem and ertapenem in OXA-48 isolates were 59.5%, 52.9% and 100%, respectively. The combination disk synergy test was 100% compatible with the molecular test results. As most of the OXA-48 producing isolates were susceptible to meropenem but all were resistant to ertapenem, ertapenem seems to be the most sensitive agent in screening carbapenemases in areas where OXA-48 is prevalent and phenotypic combination tests can be useful in centers where molecular tests are not available.Wo

Evaluation of 2015-2016 MOTAKK HBV DNA and HCV RNA External Quality Assessment National Program Results

MOTAKK, as a national external quality control program has been launched to evaluate the molecular detection of viral infections including HBV DNA and HCV RNA in molecular microbiology diagnostic laboratories in Turkey. This program is prepared in compliance with ISO 17043:2010 (Conformity assessment general requirements for proficiency testing) standards, and aims to take the place of external quality control programs from abroad, contributing to standardization and accuracy of molecular diagnostic tests in our country. The aim of this study was to evaluate 2015 and 2016 results of the MOTAKK External Quality Control Program for HBV DNA and HCV RNA viral load. The calls were announced on the web page of MOTAKK (www.motakk.org). The quality control samples were sent to participating laboratories in 2015 and 2016. Main stocks were prepared from patients with chronic hepatitis B and C who had viral load detection with reference methods according to WHO reference materials for viral load studies to improve quality control sera. From these main stocks, samples with different viral loads were prepared from dilutions of plasma with HBV, HCV, HAV, HIV, Parvovirus B19 and CMV negative serologic markers. Quality control samples were sent to the participating laboratories along with the negative samples in the cold chain. The laboratories accomplished the related tests within 2-3 weeks and entered their results on the MOTAKK web page. These results were analysed according to ISO 13528 (Statistical methods for use in proficiency testing by interlaboratory comparison) and scoring reports were created by a software developed by MOTAKK and sent to participating labs. Each laboratory evaluated their own results in comparison with the other laboratory results, reassessed the tests via observing the distance from the mean result and the reference values. The number of laboratories participating in the HBV DNA and HCV RNA external quality control program was 70-73 in 2015-2016. Participants were able to comply with the program tools, registering, entering results and receiving the results reports problem. In HBV panel, 72.6-89.1% and 84.7-90.3% of the participant laboratories were in 1 standard deviation (SD) in 2015-2016, respectively. In HCV panel, 70.8-89.1% and 84.7-90.3% of the participant laboratories were in 1 SD in 2015-2016, respectively. A national external quality control program for HBV DNA and HCV RNA in Turkey has been prepared for the first time with this project and implemented successfully. All the data provided in the MOTAKK external quality control program final report, compensate all the data provided by the quality control program final reports from abroad; additionally, the report allows comparison of used technologies and commercial products

Evaluation of the results of MOTAKK hepatitis C virus RNA genotyping and hepatitis delta virus external quality assessment programs during 2015-2016

Background/Aims: To evaluate the HCV RNA genotyping and HDV RNA tests that are performed in molecular microbiology laboratories in Turkey as part of a national external quality assessment programme, MOTAKK (Molekuler Tanida Kalite Kontrol) (English translation: Quality control in molecular diagnostics). Materials and Methods: Plasmas having different HCV RNA genotypes were used to prepare HCV genotype control sera. The HDV RNA main stock was prepared from patients with chronic delta hepatitis who had a significant amount of viral load detected, as per the WHO reference materials on viral load studies that were compiled for the purpose of developing HDV RNA control sera. Samples with different viral loads were prepared from this main stock by dilution. The prepared controls were delivered to the registered laboratories. The laboratories carried out the relevant tests and entered their results via the MOTAKK web page. External quality assessment (EQA) reports of the participants were uploaded to the website as well. Results: In total, there were 23 participating laboratories, out of which 20 exclusively performed HCV genotyping, and 15 and 16 only performed HDV RNA in 2015 and 2016, respectively. The success rate of the results of the HCV genotype was 56-96\% in 2015 and 30-95\% in 2016. The tube with a 30\% success rate had a recombinant type of HCV, therefore, it could not be detected in most of the laboratories. The HDV RNA results were evaluated qualitatively. Accordingly, HDV RNA detection rates of participant laboratories were 71-100\% in 2015 and 50-100\% in 2016. Conclusion: This study was the first national external quality control program in Turkey regarding HCV RNA genotyping and HDV RNA in the field of molecular microbiology, and it was implemented successfully